Chinese

advanced search

News & Events

Home News & Events Content

The second-batch medical aid team from Shaanxi Province publishes research outcomes in top-notch journals in the field of infection

Updated: Apr 22, 2020
From:
Edited by: Liu Huiting
Hits:

During the 65 days from February 2 to April 6, 2020 in Hubei Province, the second batch of medical aid team from Shaanxi Province, led by Professor Ma Xiancang from the First Affiliated Hospital of Xi 'an Jiaotong University (XJTU), treated a total of 113 COVID-19 patients and successfully completed the front-line anti-epidemic task.

In addition to clinical work, Professor Ma Xiancang of our hospital and Professor Wang Yadan, Director of the 7thfloor Ward in the Union Hospital of Tongji Medical College (West District), organized all team members to analyze and summarize the patient data of the ward area and published relevant research outcomes inClinical Infection Diseases(IF: 9.055) andJournal of Infection(IF: 5.099), top-notch journals in the field of infection. Professor Ma Xiancang is the corresponding author and Zhou Bo, Physician from Department of Respiratory and Critical Care Medicine of our hospital and a member of the second batch of medical aid team, is the first author.

The manuscript entitledThe duration of viral shedding of discharged patients with severe COVID-19is accepted and published byClinical Infectious Diseases. In this study, 41 discharged patients with severe COVID-19 from the ward were recruited. The results showed that the median duration of viral shedding (from onset of symptoms to the final negative nucleic acid test) of patients with severe COVID-19 was 31 days, whereas no statistical difference was observed according to age and sex, indicating that all patients with severe COVID-19 should complete adequate course of treatment regardless of age and sex.

Another manuscript entitledThe clinical characteristics of myocardial injury in severe and very severe patients with 2019 Novel Coronavirus Diseasewas accepted byJournal of Infection. A total of 26 patients with severe COVID-19 and 8 patients with very severe COVID-19 were enrolled in this investigation. Laboratory test demonstrated that the expression levels of cardiac troponin I (cTnI), creatine kinase (CK), α-hydroxybutyrate dehydrogenase (HBDB) and lactate dehydrogenase (LDH) in patients with very severe COVID-19 were significantly higher than those in patients with severe COVID-19, indicating that patients with very severe COVID-19 develop severe myocardial injury. The significant increase of cardiac biomarkers predicts the critical condition and poor prognosis of patients with COVID-19.

Previous:Our hospital exchanges experience in fight against COVID-19 with three African countries via video conference
Next:Professor Yuan Zuyi publishes CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic in Circulation

Copyright (c) 2011, First Affiliated Hospital of Xi 'an Jiaotong University Shaanxi ICP for 12009712-3